Home > Insider Trading > Filing (0001209191-14-021901)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1326104	Jeffrey David Medeiros	1300 North Kellogg Drive Suite D Anaheim CA 92807	Evp And Cto	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-17	1,041	$14.24	121,080	No	4	M	Direct
Common Stock	Acquisiton	2014-03-17	1,250	$35.78	122,330	No	4	M	Direct
Common Stock	Disposition	2014-03-17	1,664	$62.36	120,666	No	4	S	Direct
Common Stock	Disposition	2014-03-17	627	$63.25	120,039	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-03-17	1,041	$0.00	1,041	$14.24
Common Stock	Stock Option (right to buy)	Disposition	2014-03-17	1,250	$0.00	1,250	$35.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,459		2021-02-15	No	4	M	Direct
28,750		2022-02-14	No	4	M	Direct

Footnotes

Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
The option was granted on 02/16/2011 for the right to buy 50,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
The option was granted on 02/15/2012 for the right to buy 60,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00-$62.79 and $63.02-63.68, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.